Rankings
▼
Calendar
PHAT Q1 2022 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PHAT
Phathom Pharmaceuticals, Inc.
$891M
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$128,000
Operating Income
-$38M
Net Income
-$41M
EPS (Diluted)
$-1.14
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$45M
Free Cash Flow
-$45M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$149M
Total Liabilities
$111M
Stockholders' Equity
$38M
Cash & Equivalents
$138M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$128,000
-$125,000
-2.4%
Operating Income
-$38M
-$34M
-12.9%
Net Income
-$41M
-$35M
-16.7%
← FY 2022
All Quarters
Q2 2022 →